Potential Renoprotective Effects of Silymarin Against Nephrotoxic Drugs: A Review of Literature


  • Foroud Shahbazi
  • Simin Dashti-Khavidaki
  • Hossein Khalili
  • Mahboob Lessan-Pezeshki




Drug-induced nephrotoxicity (DIN) accounts for up to sixty percent of hospital acquired acute kidney injury. Several efforts have been made to reduce drug-induced renal damage; however, DIN remains a matter of concern, with substantial impact on patients and the health system. Silymarin is a drug that has been used for many years in alternate and modern medicine for treating hepatic diseases. Its antioxidant, anti-inflammatory and anti-apoptotic effects make it an interesting herbal medicine, and these properties have implicated this compound as a potential renoprotective agent. Based on the findings from animal studies, this review concluded that silymarin might exert significant protective or ameliorative effects against drug-induced kidney disease, especially against cisplatin-induced renal damage. Whether the protective administration of silymarin could be an effective clinical pharmacological strategy to prevent DIN is a question that remains to be answered in clinical trials. This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For Readers”) may comment by clicking on ABSTRACT on the issue’s contents page.


Download data is not yet available.




How to Cite

Shahbazi, F., Dashti-Khavidaki, S., Khalili, H., & Lessan-Pezeshki, M. (2012). Potential Renoprotective Effects of Silymarin Against Nephrotoxic Drugs: A Review of Literature. Journal of Pharmacy & Pharmaceutical Sciences, 15(1), 112–123. https://doi.org/10.18433/J3F88S



Review Articles